Amneal Pharmaceuticals Inc (AMRX)
8.245
-0.16
(-1.85%)
USD |
NASDAQ |
Nov 05, 16:00
8.245
0.00 (0.00%)
After-Hours: 16:07
Amneal Pharmaceuticals Total Liabilities (Quarterly): 3.514B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.514B |
| March 31, 2024 | 3.473B |
| December 31, 2023 | 3.453B |
| September 30, 2023 | 3.496B |
| June 30, 2023 | 3.518B |
| March 31, 2023 | 3.464B |
| December 31, 2022 | 3.615B |
| September 30, 2022 | 3.657B |
| June 30, 2022 | 3.851B |
| March 31, 2022 | 3.482B |
| December 31, 2021 | 3.573B |
| September 30, 2021 | 3.591B |
| June 30, 2021 | 3.633B |
| Date | Value |
|---|---|
| March 31, 2021 | 3.593B |
| December 31, 2020 | 3.661B |
| September 30, 2020 | 3.689B |
| June 30, 2020 | 3.686B |
| March 31, 2020 | 3.987B |
| December 31, 2019 | 3.319B |
| September 30, 2019 | 3.308B |
| June 30, 2019 | 3.513B |
| March 31, 2019 | 3.585B |
| December 31, 2018 | 3.456B |
| September 30, 2018 | 3.667B |
| June 30, 2018 | 3.605B |
| December 31, 2017 | 1.717B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.319B
Minimum
Dec 2019
3.987B
Maximum
Mar 2020
3.592B
Average
3.591B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Nutriband Inc | 1.173M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.510B |
| Shareholders Equity (Quarterly) | -57.46M |
| Debt to Equity Ratio | -45.47 |
| Current Ratio | 1.333 |
| Net Debt Paydown Yield | 1.21% |